Observational Study
Copyright ©The Author(s) 2022.
World J Gastrointest Pharmacol Ther. Jul 5, 2022; 13(4): 57-66
Published online Jul 5, 2022. doi: 10.4292/wjgpt.v13.i4.57
Table 2 Demographic and clinical characteristics according to normal and low bone mineral density of patients with ulcerative colitis
Variable
Normal BMD (n = 40)
Low BMD (n = 28)
P value
Age (yr), median (IR)37.5 (30.0-43.0)40.0 (32.5-46.0)0.193
Age group, n (%)
< 45 yr31 (77.5)20 (71.4)0.57
≥ 45 yr9 (22.5)8 (28.6)
Sex, n (%)
Male11 (27.5)15 (53.6)0.03
Female29 (72.5)13 (46.4)
Regular physical activity, n (%)
No27 (67.5)25 (89.3)0.04
Yes13 (32.5)3 (10.7)
Duration of illness (yr), median (IR)5.0 (2.0-9.0)4.5 (1.2-6.7)0.98
Extent of disease, n (%)
Proctitis12 (30.0)1 (3.6)0.01
Left colitis11 (27.5)14 (50.0)
Extensive colitis17 (42.5)13 (46.4)
Use of glucocorticoids, n (%)
No33 (84.6)22 (78.6)0.75
Yes6 (15.4)6 (21.4)
Use of glucocorticoids ≥ 3 mo, n (%)
No3 (50.0)1 (16.7)0.54
Yes3 (50.0)5 (83.3)
Accumulated dose of glucocorticoids (g), median (IR)1.8 (1.3-2.3)1.5 (1.1-3.5)0.55
Serum calcium (mmol/L), median (IR)2.3 (2.3-2.4)2.2 (2.2-2.3)0.03
Serum albumin (g/dL), median (IR)4.4 (4.1-4.6)4.3 (4.0-4.5)0.57
PCR mg/dL, median (IR)3.1 (0.9-6.1)1.6 (1.6-6.3)0.56